Befit Pharma Private Limited
About Befit Pharma Private Limited
Data last updated:
Befit Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and surgical equipment segment of the healthcare sector. It was incorporated on 19 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2019PTC359028. Its GSTIN is 09AAICB8132B1ZW (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sandeep and Anoop Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1441 F/F Gali No 13 Govindpuri Near, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.35 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹34,037 (net margin 1.2%) and EBITDA of ₹50,468 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years.
Company details
Contact details
Befit Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1441 F/F Gali No 13 Govindpuri Near, New Delhi, Delhi, India – 110019
- IndustryHealthcare, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments, Manufacturing
To see the full contact details of Befit Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Befit Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Befit Pharma Private Limited, buy the company report.
Financials of Befit Pharma Private Limited
FY 2025 filings availableBefit Pharma Private Limited reported revenue of ₹28.35 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 116% over three years, including 19% growth in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,468 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,037 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Befit Pharma Private Limited, buy the company report.
Board of directors of Befit Pharma Private Limited
Befit Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Also directs: Raisan Pharmaceuticals Private Limited | Director | 19 Dec 2019 | 6 Years 10 Months | Current |
| Anoop Patel | Director | 19 Dec 2019 | 6 Years 10 Months | Current |
Peer comparison
Befit Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nerib Life Science Private Limited | ₹28.5 Lakh (FY 2024) | 34.0% | Opt. Akh, Gujarat, India | |||
| A-One Dyes and Chemicals Pvt Ltd | ₹28.46 Lakh (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Susruta Biotech Private Limited | ₹28.44 Lakh (FY 2021) | 3.0% | Lucknow, Uttar Pradesh, India | |||
| Allen Ginsberg Laboratories Private Limited | ₹28.44 Lakh (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Gaso Cosmetics Private Limited | ₹28.39 Lakh (FY 2025) | -62.0% | Bahadurgarh, Haryana, India | |||
| Befit Pharma Private Limitedthis company | ₹28.35 Lakh (FY 2025) | ₹34,037 | 1.2% | 19.0% | New Delhi, Delhi, India | |
| Panther Health Care Private Limited | ₹28.35 Lakh (FY 2022) | -47.0% | Delhi, India | |||
| Scienzyma Private Limited | ₹28.34 Lakh (FY 2024) | Srirangam, Tamil Nadu, India | ||||
| Thripura Industrial Enterprises Private Limited | ₹28.33 Lakh (FY 2025) | -29.0% | Aluva, Kerala, India | |||
| Oasis Crop Care Private Limited | ₹28.32 Lakh (FY 2024) | -66.0% | Raipur, Chhattisgarh, India | |||
| Vayuputra Coal Traders Private Limited | ₹28.26 Lakh (FY 2024) | 293699.0% | Parkal, Telangana, India |
To see the full peer comparison of Befit Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Befit Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Befit Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Befit Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICB8132B1ZW | Uttar Pradesh | Active | 25 Aug 2020 |
To see the full GST registrations and return filing status of Befit Pharma Private Limited, buy the company report.
Recent activity
Befit Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Anoop Patel was appointed as Director on 19 Dec 2019.
Frequently asked questions
Befit Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical and surgical equipment, within the healthcare industry. It was incorporated on 19 December 2019 (7+ years old) and is registered under CIN U33110DL2019PTC359028.
Befit Pharma has 2 current directors:
- Sandeep - Director
- Anoop Patel - Director
The latest financial statements of Befit Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Befit Pharma is 09AAICB8132B1ZW, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Befit Pharma is U33110DL2019PTC359028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Befit Pharma was incorporated on 19 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Befit Pharma by revenue are Nerib Life Science Private Limited, A-One Dyes and Chemicals Pvt Ltd, Susruta Biotech Private Limited, Allen Ginsberg Laboratories Private Limited, Gaso Cosmetics Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anoop Patel was appointed as Director on 19 Dec 2019. Sandeep was appointed as Director on 19 Dec 2019.
The registered office of Befit Pharma is at 1441 FF Gali No 13 Govindpuri Near, New Delhi, Delhi, India – 110019.
Befit Pharma operates in the healthcare industry, in the medical and surgical equipment segment.
Befit Pharma can be reached at its registered office: 1441 FF Gali No 13 Govindpuri Near, New Delhi, Delhi, India – 110019.